参考文献/References:
[1] Armenian SH,Lacchetti C,Barac A,et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers:American Society of Clinical Oncology Clinical Practice Guideline[J]. J Clin Oncol,2017,35(8):893-911.
[2] Lyon AR,López-Fernández T,Couch LS,et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association(EHA),the European Society for Therapeutic Radiology and Oncology(ESTRO) and the International Cardio-Oncology Society(IC-OS)[J]. Eur Heart J,2022,43(41):4229-4361.
[3] Curigliano G,Cardinale D,Suter T,et al. Cardiovascular toxicity induced by chemotherapy,targeted agents and radiotherapy:ESMO Clinical Practice Guidelines[J]. Ann Oncol,2012,23(suppl 7):vii155-vii166.
[4] Lavine KJ,Pinto AR,Epelman S,et al. The macrophage in cardiac homeostasis and disease:JACC Macrophage in CVD Series(Part 4)[J]. J Am Coll Cardiol,2018,72(18):2213-2230.
[5] Leuschner F,Nahrendorf M. Novel functions of macrophages in the heart:insights into electrical conduction,stress,and diastolic dysfunction[J]. Eur Heart J,2020,41(9):989-994.
[6] Martinez FO,Sica A,Mantovani A,et al. Macrophage activation and polarization[J]. Front Biosci,2008,13:453-461.
[7] Narezkina A,Narayan HK,Zemljic-Harpf AE. Molecular mechanisms of anthracycline cardiovascular toxicity[J]. Clin Sci(Lond),2021,135(10):1311-1332.
[8] Koleini N,Kardami E. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity[J]. Oncotarget,2017,8(28):46663-46680.
[9] Ye J,Wang Y,Xu Y,et al. Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice[J]. Redox Biol,2020,36:101636.
[10] Gambardella J,Santulli G,Fiordelisi A,et al. Infiltrating macrophages amplify doxorubicin-induced cardiac damage:role of catecholamines[J]. Cell Mol Life Sci,2023,80(11):323.
[11] Krysko DV,Kaczmarek A,Krysko O,et al. TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation[J]. Cell Death Differ,2011,18(8):1316-1325.
[12] Zhang H,Xu A,Sun X,et al. Self-maintenance of cardiac resident reparative macrophages attenuates doxorubicin-induced cardiomyopathy through the SR-A1-c-Myc axis[J]. Circ Res,2020,127(5):610-627.
[13] Chen S,Huang Y,Huang S,et al. M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes[J]. PLoS One,2023,18(7):e0288422.
[14] Sauter KA,Wood LJ,Wong J,et al. Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome[J]. Cancer Biol Ther,2011,11(12):1008-1016.
[15] Kobayashi M,Usui F,Karasawa T,et al. NLRP3 deficiency reduces macrophage interleukin-10 production and enhances the susceptibility to doxorubicin-induced cardiotoxicity[J]. Sci Rep,2016,6:26489.
[16] Tan R,Cong T,Xu G,et al. Anthracycline-induced atrial structural and electrical remodeling characterizes early cardiotoxicity and contributes to atrial conductive instability and dysfunction[J]. Antioxid Redox Signal,2022,37(1-3):19-39.
[17] Sun Z,Zhou D,Xie X,et al. Cross-talk between macrophages and atrial myocytes in atrial fibrillation[J]. Basic Res Cardiol,2016,111(6):63.
[18] Hulsmans M,Schloss MJ,Lee IH,et al. Recruited macrophages elicit atrial fibrillation[J]. Science,2023,381(6654):231-239.
[19] Meziani L,Deutsch E,Mondini M. Macrophages in radiation injury:a new therapeutic target[J]. Oncoimmunology,2018,7(10):e1494488.
[20] Sharma UC,Sonkawade SD,Spernyak JA,et al. A small peptide Ac-SDKP inhibits radiation-induced cardiomyopathy[J]. Circ Heart Fail,2018,11(8):e004867.
[21] Cao C,Wu R,Wang S,et al. Elucidating the changes in the heterogeneity and function of radiation-induced cardiac macrophages using single-cell RNA sequencing[J]. Front Immunol,2024,15:1363278.
[22] Teresa Pinto A,Laranjeiro Pinto M,Patrícia Cardoso A,et al. Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities[J]. Sci Rep,2016,6:18765.
[23] Sharma UC,Pokharel S,van Brakel TJ,et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction[J]. Circulation,2004,110(19):3121-3128.
[24] Zhang XZ,Li QL,Tang TT,et al. Emerging role of macrophage-fibroblast interactions in cardiac homeostasis and remodeling[J]. JACC Basic Transl Sci,2024,10(1):113-127.
[25] Tang Y,Wang B,Sun M,et al. Mass cytometry reveals immunological response to radiation-induced cardiac fibrosis in mice[J]. bioRxiv,2021.DOI:10.1101/2021.02.23.432001.
[26] Hulsmans M,Sam F,Nahrendorf M. Monocyte and macrophage contributions to cardiac remodeling[J]. J Mol Cell Cardiol,2016,93:149-155.
[27] Gergely TG,Drobni ZD,Sayour NV,et al. Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors[J]. Basic Res Cardiol,2025,120(1):187-205.
[28] Johnson DB,Balko JM,Compton ML,et al. Fulminant myocarditis with combination immune checkpoint blockade[J]. N Engl J Med,2016,375(18):1749-1755.
[29] Palaskas NL,Segura A,Lelenwa L,et al. Immune checkpoint inhibitor myocarditis:elucidating the spectrum of disease through endomyocardial biopsy[J]. Eur J Heart Fail,2021,23(10):1725-1735.
[30] Ma P,Liu J,Qin J,et al. Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis[J]. Circulation,2024,149(1):48-66.
[31] Huang YV,Lee D,Sun Y,et al. A Novel therapeutic approach using CXCR3 blockade to treat immune checkpoint inhibitor-mediated myocarditis[J].bioRxiv,2024.
[32] Huang X,Venet F,Wang YL,et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis[J]. Proc Natl Acad Sci U S A,2009,106(15):6303-6308.
[33] Champion SN,Stone JR. Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms[J]. Mod Pathol,2020,33(1):99-108.
[34] Xia W,Zou C,Chen H,et al. Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling[J]. Cell Death Dis,2020,11(7):575.
[35] Xia W,Chen H,Chen D,et al. PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction[J]. J Immunother Cancer,2020,8(2):e001293.
[36] Wang X,Chen J,Shen Y,et al. Baricitinib protects ICIs-related myocarditis by targeting JAK1/STAT3 to regulate macrophage polarization[J]. Cytokine,2024,179:156620.
[37] ?iháková D. T cells and macrophages drive pathogenesis of immune checkpoint inhibitor myocarditis[J]. Circulation,2024,149(1):67-69.
相似文献/References:
[1]冯泽豪 姜萌 卜军.心脏磁共振评价化疗所致心肌损伤的研究进展[J].心血管病学进展,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
FENG Zehao,JIANG Meng,PU Jun.Cardiovascular Magnetic Resonance for Detection of Myocardial Impairments Caused by Chemotherapy[J].Advances in Cardiovascular Diseases,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
[2]张伟 黄从新.巨噬细胞与心血管稳态和疾病[J].心血管病学进展,2019,(9):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
ZHANG Wei,HUANG Congxin.Macrophages are Associated with Cardiovascular Homeostasis and Diseases[J].Advances in Cardiovascular Diseases,2019,(5):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
[3]李凤鹏 张军.2型心肌梗死和心肌损伤的研究进展[J].心血管病学进展,2019,(9):1275.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.023]
LI Fengpeng,ZHANG Jun.Type 2 Myocardial Infarction and Myocardial Injury[J].Advances in Cardiovascular Diseases,2019,(5):1275.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.023]
[4]布热比古力·阿布力米提 付真彦.乳腺癌药物治疗与心肌损伤[J].心血管病学进展,2020,(8):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
Burebiguli·abulimitiFU Zhenyan.Drug Therapy of Breast Cancer and Assosiated Myocardial Damage[J].Advances in Cardiovascular Diseases,2020,(5):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
[5]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(5):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
[6]陈涛 张大勇 袁明 魏天龙.急性ST段抬高型心肌梗死患者血miRNA-499a与心肌损伤标志物的相关性分析[J].心血管病学进展,2020,(9):994.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.025]
CHEN Tao,ZHANG Dayong,YUAN Ming,et al.Correlation Between Serum miRNA-499a and Myocardial Injury Markers in Patients with Acute ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(5):994.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.025]
[7]汪汉,刘汉雄,蔡琳.2019冠状病毒病的心血管表现[J].心血管病学进展,2020,(11):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
WANG Han,LIU Hanxiong,CAI Lin.Cardiovascular Profiles in Corona V irus Disease 2019[J].Advances in Cardiovascular Diseases,2020,(5):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[8]陈远洋 王志维.供体巨噬细胞在心脏移植中的研究进展[J].心血管病学进展,2022,(6):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
CHEN Yuanyang,WANG Zhiwei.Donor Macrophages in Heart Transplantation[J].Advances in Cardiovascular Diseases,2022,(5):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
[9]付韫韬 赵庆彦?/html>.巨噬细胞调控离子通道致心律失常研究的最新进展[J].心血管病学进展,2022,(2):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
FU Yuntao ZHAO Qingyan.Macrophages Regulating Ion Channels to Induce Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(5):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
[10]陈乾 秦铭 徐志云.单核/巨噬细胞与主动脉瓣钙化研究进展[J].心血管病学进展,2022,(10):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]
CHEN Qian,QIN Ming,XU Zhiyun.Aortic Valve Calcification Caused by Mononuclear Phagocyte System[J].Advances in Cardiovascular Diseases,2022,(5):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]